BeOne Medicines (ONC) Free Cash Flow Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.71% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -10.65% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 31.42% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 31.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.07% |
| Dec 31, 2025 | 38.30% |
| Sep 30, 2025 | 37.67% |
| Jun 30, 2025 | 37.81% |
| Mar 31, 2025 | 61.62% |
| Dec 31, 2024 | 22.22% |
| Sep 30, 2024 | 28.00% |
| Jun 30, 2024 | 24.11% |
| Mar 31, 2024 | -77.46% |
| Dec 31, 2023 | -17.29% |
| Sep 30, 2023 | 29.59% |
| Jun 30, 2023 | -20.83% |
| Mar 31, 2023 | -19.98% |
| Dec 31, 2022 | -10.30% |
| Sep 30, 2022 | -37.43% |
| Jun 30, 2022 | -92.62% |
| Mar 31, 2022 | -13.28% |
| Dec 31, 2021 | 49.08% |
| Sep 30, 2021 | -48.68% |
| Jun 30, 2021 | -59.71% |
| Mar 31, 2021 | 41.36% |
| Dec 31, 2020 | -76.74% |
| Sep 30, 2020 | -207.63% |
| Jun 30, 2020 | -66.51% |
| Mar 31, 2020 | -112.43% |
| Dec 31, 2019 | -87.96% |
| Sep 30, 2019 | -153.61% |
| Jun 30, 2019 | -34.56% |
| Mar 31, 2019 | -103.07% |
| Dec 31, 2018 | -124.70% |
| Sep 30, 2018 | -144.35% |
| Jun 30, 2018 | -163.71% |
| Mar 31, 2018 | -154.31% |